Photo of Brent Keith Hollenbeck,  MD

Brent Keith Hollenbeck, MD

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 726-3010


bhollenbeck@mgh.harvard.edu

Brent Keith Hollenbeck, MD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Professor, Surgery, Harvard Medical School
  • Chair, Urology, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Hollenbeck is committed to being a force-multiplier in the field by catalyzing the scientific and professional trajectories of colleagues and learners. His lab has been continuously funded since 2007 and has served as a substrate for learners to pursue their own avenues of discovery. He is supported by R01s from the NCI, AHRQ and NIA and a Research Scholar Grant from the American Cancer Society. His research focuses on how financial incentives influence physician behavior and affect the quality of care, particularly with respect to prostate cancer.

Dr. Hollenbeck has served or serves as primary research mentor for 4 predoctoral students and 22 postdoctoral fellows and faculty. While measures of academic success, including extramural funding and scholarship, are tangible and imperative, they are a byproduct of his most important contribution of inspiring others to sustain impactful careers in science and cancer-related research. Among his mentees, 10 have successfully competed for career development awards and 8 have secured independent (R01 or similar) funding. Currently, 7 of his mentees serve as PI of 13 active R01s and one research-focused training award.

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Hill D, Kaufman SR, Oerline MK, Faraj K, Caram MEV, Shahinian VB, Hollenbeck BK, Maganty A. In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. JNCI Cancer Spectr 2023. PubMed
  • Maganty A, Hollenbeck BK, Kaufman SR, Oerline MK, Lai LY, Caram MEV, Shahinian VB. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer. Urology 2023; 177:95-102. PubMed
  • Post B, Hollenbeck BK, Norton EC, Ryan AM. Hospital-physician integration and clinical volume in traditional Medicare. Health Serv Res 2023. PubMed
  • Lai LY, Kaufman SR, Oerline M, Caram MEV, Maganty A, Shahinian VB, Hollenbeck BK. Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate Cancer. Urol Pract 2023; 10:230-235. PubMed
  • Agochukwu-Mmonu N, Qin Y, Kaufman S, Oerline M, Vince R, Makarov D, Caram MV, Chapman C, Ravenell J, Hollenbeck BK, Skolarus TA. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO Oncol Pract 2023; 19:e763-e772. PubMed
  • Hollenbeck BK, Kaufman SR, Oerline M, Modi PK, Caram MEV, Shahinian VB, Ellimoottil C. Effects of Advanced Practice Providers on Single-specialty Surgical Practice. Ann Surg 2023; 277:e40-e45. PubMed
  • Lai LY, Oerline MK, Caram MEV, Tsao PA, Kaufman SR, Hollenbeck BK, Shahinian VB. Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer. Journal of the National Cancer Institute 2022; 114:1127-1134. PubMed
  • Post B, Norton EC, Hollenbeck BK, Ryan AM. Hospital-physician integration and risk-coding intensity. 2022; 31:1423-1437. PubMed
  • Lai LY, Kaufman SR, Oerline MK, Caram MEV, Maganty A, Hollenbeck BK, Shahinian VB. Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer. JNCI Cancer Spectr 2022. PubMed
  • Lai LY, Oerline MK, Kaufman SR, Herrel LA, Skolarus TA, Dusetzina SB, Ellimoottil C, Shahinian VB, Hollenbeck BK, Caram MEV. Promotional Payments to Medical Oncologists and Urologists and Prescriptions for Abiraterone and Enzalutamide. Urology 2022; 161:50-58. PubMed
  • Herrel LA, Zhu Z, Ryan AM, Hollenbeck BK, Miller DC. Intensity of end-of-life care for dual-eligible beneficiaries with cancer and the impact of delivery system affiliation. Cancer 2021; 127:4628-4635. PubMed
  • Lai LY, Kaufman SR, Oerline MK, Ryan AM, Ellimoottil C, Caram MEV, Shahinian VB, Hollenbeck BK. Commercial Prices for Prostatectomy and Treatment among Younger, Privately Insured Men with Prostate Cancer. Urol Pract 2021; 8:611-618. PubMed
  • Modi PK, Kaufman SR, Caram ME, Ryan AM, Shahinian VB, Hollenbeck BK. Medicare Accountable Care Organizations and the Adoption of New Surgical Technology. J Am Coll Surg 2021; 232:138-145.e2. PubMed
  • Hollenbeck BK, Oerline M, Kaufman SR, Caram MEV, Dusetzina SB, Ryan AM, Shahinian VB. Promotional Payments Made to Urologists by the Pharmaceutical Industry and Prescribing Patterns for Targeted Therapies. Urology 2021; 148:134-140. PubMed
  • Caram MEV, Oerline MK, Dusetzina S, Herrel LA, Modi PK, Kaufman SR, Skolarus TA, Hollenbeck BK, Shahinian V. Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer 2020; 126:5050-5059. PubMed
  • Li BY, Urish KL, Jacobs BL, He C, Borza T, Qin Y, Min HS, Dupree JM, Ellimoottil C, Hollenbeck BK, Lavieri MS, Helm JE, Skolarus TA. Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program. JAMA Netw Open 2019; 2:e1916008. PubMed
  • Modi PK, Kaufman SR, Herrel LA, Dupree JM, Luckenbaugh AN, Skolarus TA, Hollenbeck BK, Shahinian VB. Practice-Level Adoption of Conservative Management for Prostate Cancer. J Oncol Pract 2019; 15:e863-e869. PubMed
  • Modi PK, Herrel LA, Kaufman SR, Yan P, Borza T, Skolarus TA, Schroeck FR, Hollenbeck BK, Shahinian VB. Urologist Practice Structure and Spending for Prostate Cancer Care. Urology 2019; 130:65-71. PubMed
  • Borza T, Oerline MK, Skolarus TA, Norton EC, Dimick JB, Jacobs BL, Herrel LA, Ellimoottil C, Hollingsworth JM, Ryan AM, Miller DC, Shahinian VB, Hollenbeck BK. Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery. Ann Surg 2019; 269:873-878. PubMed
  • Modi PK, Kaufman SR, Qi J, Lane BR, Cher ML, Miller DC, Hollenbeck BK, Shahinian VB, Dupree JM. National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms. Urology 2018; 120:96-102. PubMed
  • Hollingsworth JM, Oerline MK, Ellimoottil C, Herrel LA, Hollenbeck BK. Effects of the Medicare Modernization Act on Spending for Outpatient Surgery. Health Serv Res 2018; 53 Suppl 1:2858-2869. PubMed
  • Modi PK, Kaufman SR, Borza T, Yan P, Miller DC, Skolarus TA, Hollingsworth JM, Norton EC, Shahinian VB, Hollenbeck BK. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer 2018; 124:3364-3371. PubMed
  • Hollenbeck BK, Kaufman SR, Yan P, Herrel LA, Borza T, Schroeck FR, Jacobs BL, Skolarus TA, Shahinian VB. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol 2018; 73:491-498. PubMed
  • Borza T, Oreline MK, Skolarus TA, Norton EC, Ryan AM, Ellimoottil C, Dimick JB, Shahinian VB, Hollenbeck BK. Association of the Hospital Readmissions Reduction Program With Surgical Readmissions. JAMA Surg 2018; 153:243-250. PubMed
  • Borza T, Kaufman SR, Yan P, Herrel LA, Luckenbaugh AN, Miller DC, Skolarus TA, Jacobs BL, Hollingsworth JM, Norton EC, Shahinian VB, Hollenbeck BK. Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care. Cancer 2018; 124:563-570. PubMed
  • Borza T, Kaufman SR, Shahinian VB, Yan P, Miller DC, Skolarus TA, Hollenbeck BK. Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood) 2017; 36:108-115. PubMed
  • Herrel LA, Kaufman SR, Yan P, Miller DC, Schroeck FR, Skolarus TA, Shahinian VB, Hollenbeck BK. Health Care Integration and Quality among Men with Prostate Cancer. J Urol 2017; 197:55-60. PubMed
  • Herrel LA, Norton EC, Hawken SR, Ye Z, Hollenbeck BK, Miller DC. Early impact of Medicare accountable care organizations on cancer surgery outcomes. Cancer 2016; 122:2739-46. PubMed
  • Hollenbeck BK, Dunn RL, Suskind AM, Strope SA, Zhang Y, Hollingsworth JM. Ambulatory Surgery Centers and Their Intended Effects on Outpatient Surgery. Health Serv Res 2015; 50:1491-507. PubMed
  • Hollenbeck BK, Dunn RL, Suskind AM, Zhang Y, Hollingsworth JM, Birkmeyer JD. Ambulatory surgery centers and outpatient procedure use among Medicare beneficiaries. Med Care 2014; 52:926-31. PubMed
  • Jacobs BL, Zhang Y, Skolarus TA, Wei JT, Montie JE, Miller DC, Hollenbeck BK. Comparative effectiveness of external-beam radiation approaches for prostate cancer. Eur Urol 2014; 65:162-8. PubMed
  • Schroeck FR, Kaufman SR, Jacobs BL, Zhang Y, Weizer AZ, Montgomery JS, Gilbert SM, Strope SA, Hollenbeck BK. The impact of technology diffusion on treatment for prostate cancer. Med Care 2013; 51:1076-84. PubMed
  • Jacobs BL, Zhang Y, Schroeck FR, Skolarus TA, Wei JT, Montie JE, Gilbert SM, Strope SA, Dunn RL, Miller DC, Hollenbeck BK. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA 2013; 309:2587-95. PubMed
  • Jacobs BL, Zhang Y, Skolarus TA, Hollenbeck BK. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood) 2012; 31:750-9. PubMed
  • Miller DC, Hollenbeck BK. Missing the mark on prostate-specific antigen screening. JAMA 2011; 306:2719-20. PubMed
  • Hollenbeck BK, Nallamothu BK. Financial incentives and the art of payment reform. JAMA 2011; 306:2028-30. PubMed
  • Hollingsworth JM, Krein SL, Ye Z, Kim HM, Hollenbeck BK. Opening of ambulatory surgery centers and procedure use in elderly patients: data from Florida. Arch Surg 2011; 146:187-93. PubMed
  • Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, Montie JE, Lee CT, Wood DP, Miller DC. Delays in diagnosis and bladder cancer mortality. Cancer 2010; 116:5235-42. PubMed
  • Hollingsworth JM, Zhang Y, Krein SL, Ye Z, Hollenbeck BK. Understanding the variation in treatment intensity among patients with early stage bladder cancer. Cancer 2010; 116:3587-94. PubMed
  • Hollingsworth JM, Ye Z, Strope SA, Krein SL, Hollenbeck AT, Hollenbeck BK. Physician-ownership of ambulatory surgery centers linked to higher volume of surgeries. Health Aff (Millwood) 2010; 29:683-9. PubMed
  • Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD. Provider treatment intensity and outcomes for patients with early-stage bladder cancer. Journal of the National Cancer Institute 2009; 101:571-80. PubMed
  • Strope SA, Daignault S, Hollingsworth JM, Ye Z, Wei JT, Hollenbeck BK. Physician ownership of ambulatory surgery centers and practice patterns for urological surgery: evidence from the state of Florida. Med Care 2009; 47:403-10. PubMed
  • Hollingsworth JM, Krein SL, Dunn RL, Wolf JS, Hollenbeck BK. Understanding variation in the adoption of a new technology in surgery. Med Care 2008; 46:366-71. PubMed
  • Hollenbeck BK, Ye Z, Wong SL, Montie JE, Birkmeyer JD. Hospital lymph node counts and survival after radical cystectomy. Cancer 2008; 112:806-12. PubMed
  • Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007; 298:2149-54. PubMed
  • Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 2007; 109:1763-8. PubMed
  • Hollenbeck BK, Dunn RL, Miller DC, Daignault S, Taub DA, Wei JT. Volume-based referral for cancer surgery: informing the debate. J Clin Oncol 2007; 25:91-6. PubMed
  • Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, Hollenbeck BK. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006; 368:1171-9. PubMed
  • Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. Journal of the National Cancer Institute 2006; 98:1331-4. PubMed
  • Miller DC, Gruber SB, Hollenbeck BK, Montie JE, Wei JT. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. Journal of the National Cancer Institute 2006; 98:1134-41. PubMed
  • Miller DC, Wei JT, Dunn RL, Hollenbeck BK. Trends in the diffusion of laparoscopic nephrectomy. JAMA 2006; 295:2480-2. PubMed
Hide